CLINICAL_TRIALS
trial_result
· 2023-11-22
Clinical Trial Update: A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 trial of PF-04171327 for rheumatoid arthritis completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2023-11-22